4mon
GlobalData on MSNAmneal files again for FDA approval of first dihydroergotamine autoinjectorAmneal Pharmaceuticals has submitted another new drug application (NDA) for its dihydroergotamine (DHE) prefilled syringe ...
BRIDGEWATER, N.J., March 03, 2025--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company"), a global biopharmaceutical company, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results